Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy
about
An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal EffectsRisk.Individual and neighborhood predictors of mortality among HIV-positive Latinos with history of injection drug use, Florida, 2000-2011.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.Selection Bias Due to Loss to Follow Up in Cohort Studies.No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.Methodologic Issues When Estimating Risks in Pharmacoepidemiology.Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals.Bias Due to Confounders for the Exposure-Competing Risk Relationship.A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU.Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.Burn injury outcomes in patients with pre-existing diabetic mellitus: Risk of hospital-acquired infections and inpatient mortality.Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population.An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use.Missingness in the Setting of Competing Risks: from missing values to missing potential outcomes
P2860
Q28386534-31CECA63-B4C6-4587-8F0A-FD3BD7AF94B8Q35076598-F7300BF6-8E3D-4E24-92FF-68F1F0A7020FQ35952168-E57C9760-3746-4244-9CCF-535DD9D2E6B4Q36913615-A16A616C-429A-459F-AF5E-101E803301B5Q37045476-2AFBB83F-F6F8-4EFA-81D2-C58D7BB99AE5Q37227016-30652C79-90B5-4B99-B5C8-09D8C74C98EEQ38962521-F3186770-3E37-45A9-914F-D5BBC99D8C81Q40077021-208341E8-6D2F-4B72-816B-9DE9DF6B57DAQ40128898-4B5590C9-1E42-4E17-8351-EC7A1E1B7048Q40525196-67BFC99C-B45E-49DC-B829-78A71A300675Q40538737-643CC544-B1FD-4973-B039-EF0263DF81C4Q40695692-A95B0DE3-3FE5-4E22-94A3-725D2931CF0AQ40750446-3FD5B3DA-3B90-4BA8-B9B0-3A1B664FB13BQ47610442-9641057F-C7CA-4519-99C9-988D42925226Q47666901-363D2C73-4AD9-4671-813F-8CD840189F4FQ54258926-E1F34499-A2EE-433B-805C-E65D4502E338Q58573006-93AE6452-383A-4136-AC58-B60F940B5829
P2860
Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Estimation of the standardized ...... tion of antiretroviral therapy
@ast
Estimation of the standardized ...... tion of antiretroviral therapy
@en
type
label
Estimation of the standardized ...... tion of antiretroviral therapy
@ast
Estimation of the standardized ...... tion of antiretroviral therapy
@en
prefLabel
Estimation of the standardized ...... tion of antiretroviral therapy
@ast
Estimation of the standardized ...... tion of antiretroviral therapy
@en
P2093
P2860
P356
P1476
Estimation of the standardized ...... tion of antiretroviral therapy
@en
P2093
CNICS Research Network
Jeffrey N Martin
M Alan Brookhart
Mari M Kitahata
Michael J Mugavero
Stephen R Cole
William C Mathews
P2860
P304
P356
10.1093/AJE/KWU122
P407
P577
2014-06-24T00:00:00Z